Suppr超能文献

通过免疫组织化学和免疫细胞化学评估原发性乳腺癌中雌激素和孕激素受体状态的比较:267例连续病例系列

Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.

作者信息

Domanski A M, Monsef N, Domanski H A, Grabau D, Fernö M

机构信息

Department of Pathology, Skåne University Hospital, Lund, Sweden.

出版信息

Cytopathology. 2013 Feb;24(1):21-5. doi: 10.1111/j.1365-2303.2012.00997.x. Epub 2012 Jul 12.

Abstract

OBJECTIVE

The use of cytological specimens to evaluate tumour biomarkers in metastatic breast cancer lesions has attracted increased interest because of the considerable number of reports that have shown discordance between the primary tumour and metastatic lesion. Oestrogen receptor (ER) and progesterone receptor (PgR) assays are crucial for the management of patients with breast cancer, in both adjuvant and palliative settings. The aim of this study was to compare the ER and PgR immunocytochemical analysis of fine needle aspiration (FNA) samples with the immunohistochemistry (IHC) of surgical specimens and core biopsies from primary breast cancers.

METHODS

The FNA specimens were prepared as cell blocks (n = 25) or ThinPreps (n = 258) for the immunocytochemistry (IC) ER and PgR analyses. Sixteen patients were excluded because of lack of follow-up (n = 1), neoadjuvant therapy (n = 3) or cell counts in their fine needle aspirates that were too low (n = 12). The results of IC on 25 cell blocks and 242 ThinPreps were compared with IHC on the corresponding core needle biopsies (n = 16) or excised tumours (n = 251). The ER and PgR status was defined as negative (when less than 10% of the nuclei were stained) or positive (when equal or more than 10% of the nuclei were stained). Kappa statistics were used to evaluate the concordance.

RESULTS

The ER concordance was 98% with ThinPrep (κ = 0.93) and 92% with cell block (κ = 0.82). The corresponding values for PgR were 96% (κ = 0.91) and 96% (κ = 0.92).

CONCLUSIONS

Our results confirm that, in cases in which biopsies or surgical specimens are not available, IC (with either cell block or ThinPrep techniques) is a reliable method for the determination of the ER and PgR status performed under strict conditions using primary breast carcinomas, and is therefore potentially useful in metastatic settings.

摘要

目的

由于大量报告显示原发性肿瘤与转移病灶之间存在不一致性,因此使用细胞学标本评估转移性乳腺癌病灶中的肿瘤生物标志物引起了越来越多的关注。雌激素受体(ER)和孕激素受体(PgR)检测对于乳腺癌患者在辅助和姑息治疗中的管理至关重要。本研究的目的是比较细针穿刺(FNA)样本的ER和PgR免疫细胞化学分析与原发性乳腺癌手术标本和粗针活检的免疫组织化学(IHC)结果。

方法

将FNA标本制成细胞块(n = 25)或ThinPrep涂片(n = 258)用于免疫细胞化学(IC)ER和PgR分析。16例患者因缺乏随访(n = 1)、新辅助治疗(n = 3)或细针穿刺抽吸物中的细胞计数过低(n = 12)而被排除。将25个细胞块和242个ThinPrep涂片的IC结果与相应粗针活检(n = 16)或切除肿瘤(n = 251)的IHC结果进行比较。ER和PgR状态定义为阴性(当染色细胞核少于10%时)或阳性(当染色细胞核等于或超过10%时)。使用kappa统计量评估一致性。

结果

ER与ThinPrep涂片的一致性为98%(κ = 0.93),与细胞块的一致性为92%(κ = 0.82)。PgR的相应值分别为96%(κ = 0.91)和96%(κ = 0.92)。

结论

我们的结果证实,在无法获得活检或手术标本的情况下,IC(使用细胞块或ThinPrep技术)是在严格条件下使用原发性乳腺癌确定ER和PgR状态的可靠方法,因此在转移性情况下可能有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验